Opthea Stock Today
| OPT Stock | USD 3.42 0.10 3.01% |
Performance4 of 100
| Odds Of DistressLess than 50
|
Opthea is selling for under 3.42 as of the 5th of May 2024; that is 3.01 percent up since the beginning of the trading day. The stock's last reported lowest price was 3.38. Opthea has 50 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for Opthea are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 16th of May 2022 and ending today, the 5th of May 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 12th of April 2012 | Category Healthcare | Classification Health Care |
Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia. Opthea operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.. The company has 82.85 M outstanding shares of which 122.61 K shares are now shorted by investors with about 6.42 days to cover. More on Opthea
Moving against Opthea Stock
| 0.78 | RGC | Regencell Bioscience | PairCorr |
| 0.66 | PROC | Procaps Group SA Report 10th of May 2024 | PairCorr |
| 0.64 | OM | Outset MedicalInc | PairCorr |
| 0.58 | AMGN | Amgen Inc | PairCorr |
| 0.54 | GH | Guardant Health Financial Report 14th of May 2024 | PairCorr |
| 0.52 | PROCW | Procaps Group SA | PairCorr |
| 0.48 | CYTHW | Cyclo Therapeutics | PairCorr |
Follow Valuation Profit Patterns Daily Balance Of Power
Check how we calculate scores
Opthea Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Opthea's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Opthea or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Old Name | Optizen Labs SA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Opthea report their recommendations after researching Opthea's financial statements, talking to executives and customers, or listening in on Opthea's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Opthea. The Opthea consensus assessment is calculated by taking the average forecast from all of the analysts covering Opthea. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key measurements obtained from Opthea's financial statements, Opthea may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. Financial strength of Opthea is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Opthea's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Opthea's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Opthea's financial leverage. It provides some insight into what part of Opthea's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Opthea (OPT) is traded on NASDAQ Exchange in USA. It is located in 650 Chapel Street, South Yarra, VIC, Australia, 3141 and employs 24 people. Opthea is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a total capitalization of 283.18 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Opthea's market, we take the total number of its shares issued and multiply it by Opthea's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Opthea runs under Biotechnology sector within Health Care industry. The entity has 82.85 M outstanding shares of which 122.61 K shares are now shorted by investors with about 6.42 days to cover.
Opthea has about 44.63 M in cash with (120.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.01.
Check Opthea Probability Of Bankruptcy
Ownership AllocationOpthea owns a total of 82.85 Million outstanding shares. Roughly 91.0 pct. of Opthea outstanding shares are held by general public with 9.42 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Opthea Ownership Details
Opthea Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of Opthea jumping above the current price in 90 days from now is about 50.0%. The Opthea probability density function shows the probability of Opthea stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Opthea has a beta of 0.1604. This indicates as returns on the market go up, Opthea average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Opthea will be expected to be much smaller as well. Additionally, opthea has an alpha of 0.409, implying that it can generate a 0.41 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Opthea to move above the current price in 90 days from now is about 50.0 (This Opthea probability density function shows the probability of Opthea Stock to fall within a particular range of prices over 90 days) .
Opthea Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Opthea that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Opthea's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Opthea's value.| Instituion | Recorded On | Shares | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1000 | |
| Frazier Financial Advisors, Llc | 2023-12-31 | 225 | |
| Tower Research Capital Llc | 2023-12-31 | 0.0 | |
| Stonex Group Inc | 2023-12-31 | 0.0 | |
| Vgi Partners Pty Ltd | 2023-12-31 | 2.9 M | |
| Baker Bros Advisors Lp | 2023-12-31 | 2.6 M | |
| Victory Capital Management Inc. | 2023-12-31 | 884.1 K | |
| Teacher Retirement System Of Texas | 2023-12-31 | 625 K | |
| Millennium Management Llc | 2023-12-31 | 74.7 K | |
| Bank Of Montreal | 2023-12-31 | 41.2 K | |
| Bmo Capital Markets Corp. | 2023-12-31 | 41.2 K |
Opthea Historical Income Statement
Opthea Income Statement is one of the three primary financial statements used for reporting Opthea's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Opthea revenue and expense. Opthea Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Opthea's Interest Expense is comparatively stable compared to the past year. Other Operating Expenses is likely to gain to about 181.3 M in 2024, despite the fact that EBIT is likely to grow to (125.5 M). View More FundamentalsOpthea Stock Against Markets
Picking the right benchmark for Opthea stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Opthea stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Opthea is critical whether you are bullish or bearish towards Opthea at a given time. Please also check how Opthea's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Opthea without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
Opthea Corporate Management
Elected by the shareholders, the Opthea's board of directors comprises two types of representatives: Opthea inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Opthea. The board's role is to monitor Opthea's management team and ensure that shareholders' interests are well served. Opthea's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Opthea's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Karen CPA | VP Secretary | Profile | |
| CPA CPA | Chief Officer | Profile | |
| MD MA | Chief Advisor | Profile | |
| Sarika Gulhar | Executive Resources | Profile | |
| Michael Gerometta | Manufacturing Chemistry | Profile | |
| Peter MBA | Chief Officer | Profile | |
| PharmD MS | Chief Officer | Profile |
How to buy Opthea Stock?
Before investing in Opthea, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Opthea. To buy Opthea stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Opthea. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Opthea stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Opthea stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Opthea stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Opthea, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Opthea Stock please use our How to Invest in Opthea guide.
Already Invested in Opthea?
The danger of trading Opthea is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Opthea is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Opthea. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Opthea is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Opthea is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Opthea Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Opthea Stock. Highlighted below are key reports to facilitate an investment decision about Opthea Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opthea. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Opthea Stock please use our How to Invest in Opthea guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Opthea Stock analysis
When running Opthea's price analysis, check to measure Opthea's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opthea is operating at the current time. Most of Opthea's value examination focuses on studying past and present price action to predict the probability of Opthea's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opthea's price. Additionally, you may evaluate how the addition of Opthea to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |
Is Opthea's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opthea. If investors know Opthea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opthea listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.41) | Revenue Per Share 0.008 | Quarterly Revenue Growth 0.026 | Return On Assets (0.64) | Return On Equity (33.83) |
The market value of Opthea is measured differently than its book value, which is the value of Opthea that is recorded on the company's balance sheet. Investors also form their own opinion of Opthea's value that differs from its market value or its book value, called intrinsic value, which is Opthea's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opthea's market value can be influenced by many factors that don't directly affect Opthea's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opthea's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opthea is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opthea's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.